The impact of additional mineralocorticoid receptor antagonist on guideline-recommended medical therapy in acute heart failure patients with ischemic heart disease.

28 August 2018 (09:07 - 09:16)
Organised by:
Congress Presentation Part of: Cardiovascular drug therapy in special populations Aldosterone Antagonists ESC Premium Access ESC Congress 2018

ESC 365 is supported by

ESC 365 is supported by